Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells

Inflammatory Bowel Diseases

Volumn 11, Issue 9, 2005, Pages 814-819

  Møller, Peter Lange ^a   Pærregaard, Anders ^b   Gad, Monika ^c   Kristensen, Nanna Ny ^c   Claesson, Mogens Helweg ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Colitis; Cytokines; Histopathology; Probiotics; Scid mice

Indexed keywords

CD4 ANTIGEN; CYTOKINE; DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 4; MEROPENEM; PROBIOTIC AGENT; VANCOMYCIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CELL TRANSPLANTATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOBLAST; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; FEMALE; INTERLEUKIN-4; LACTOBACILLUS; LACTOBACILLUS REUTERI; MICE; MICE, INBRED BALB C; MICE, SCID; PROBIOTICS; RECTUM; THIENAMYCINS; VANCOMYCIN; WATER SUPPLY;

EID: 25444475213     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000175906.77340.15     Document Type: Article

References (30)

1. Pærregaard A. Probiotics in allergy prevention and therapy. Ann Nestlé. 2003;61:79-88.
2. Dunne C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis. 2001;7:136-145.
3. Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology. 2000;119:584-587.
4. Metchnikoff E. The Prolongation of Life. New York: Putnam's Sons; 1998.
5. Jacobsen CN, Nielsen VR, Hayford AE, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of four selected strains in humans. Appl Environ Microbiol. 1999;65:4949-4956.
6. Rosenfeldt V, Michaelsen KF, Jacobsen CN, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhoea. Pediatr Infect Dis J. 2002;21:411-416.
7. Rosenfeldt V, Michaelsen KF, Jacobsen CN, et al. Effect of probiotic Lactobacillus strains on acute diarrhea a cohort of nonhospitalized children attending day care centers. Pediatr Infect Dis J. 2002;21:417-419.
8. Rosenfeldt V, Benfeldt E, Valerius NH, et al. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr. 2004;145:612-616.
9. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102:445-447.
10. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
11. Bregenholt S, Claesson MH. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur J Immunol. 1998;28:379-389.
12. Brimnes J, Reimann J, Nissen MH, et al. Enteric bacterial antigens activate CD4+ T cells from scid mice with inflammatory bowel disease. Eur J Immunol. 2001;31:23-31.
13. Perdigon G, Alvarez S, Nader de Marcias M, et al. Oral administration of lactic acid bacteria increases intestinal immunity in response to enteropathogens. J Food Prot. 1990;53:404-410.
14. Claesson MH, Bregenholt S, Bonhagen K, et al. Colitis inducing portency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness and CD45RB surface phenotype. J Immunol. 1999;162:3702-3710.
15. Brimnes J, Reimann J, Claesson MH. Immunoglobulin leakiness in scid with CD4+ T cell induced chronic colitis. Clin Immunol. 2000;96:222-229.
16. Schmidt PT, Hartmann B, Bregenholt S, et al. Deficiency of the intestinal growth factor, glucagon-like peptide 2 (GLP-2), in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells. Scand J Gastroenterol. 2000;35:522-527.
17. Gad M, Brimnes J, Claesson MH. CD4+ T regulatory cells from the colonic lamina propria of normal mice inhibit proliferation of enterobacteria-reactive, disease-inducing Th1-cells from scid mice with colitis. Clin Exp Immunol. 2003;131:34-40.
18. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Ann Rev Immunol. 2002;20:495-549.
19. high T cells to SCID recipients. J Immunol. 1997;158:3464-3473.
20. + T cells in the regulation of inflammatory responses in the intestine. Res Immunol. 1997;148:576-581.
21. Madsen KL, Doyle JS, Tavernini MM, et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 2000;118:1094-1105.
22. Prantera C, Zannoni F, Scribano ML, et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol. 1996;91:328-332.
23. Dieleman LA, Goerres MS, Arends A, et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003;52:370-376.
24. Dunne C, Murphy L, Flynn S, et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999;76:279-292.
25. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66:5224-5231.
26. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999;116:1107-1114.
27. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10- deficient mice. Inflamm Bowel Dis. 2002;8:71-80.
28. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000;289:1352-1355.
29. Rutgeerts P, Van Deventer S, Schreiber S. Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition. Aliment Pharmacol Ther. 2003;17:1435-1450.
30. Ito H. IL-6 and Crohn's disease. Curr Drug Targets Inflam Allergy. 2003;2:125-130.